Carestream Showcases Works-in-Progress Lesion Management Tools on its PACS Workstation

Carestream HealthCarestream Health showcased innovative works-in-progress lesion management 3D tools on its CARESTREAM Vue PACS workstation at the annual "Workstation Face-Off," which is part of the annual International Symposium on Multidetector-Row CT.

The new lesion management application enables radiologists to automatically measure a lesion and compare it to previous findings in an MR or CT scan. Each result can be bookmarked and can include comments and data for easy access. This comprehensive data comparison method is ideal for oncology exams and provides localisation, measurements, follow-up and comparison of findings that can help eliminate viewer variation and enhance accuracy.

"Our new lesion management application is designed to significantly enhance assessments of oncology patients by automating access to specific measurements from previous exams," said Cristine Kao, Carestream's Global Marketing Manager, Healthcare Information Solutions. "In addition to facilitating a faster diagnosis, it can also improve communication and collaboration between radiologists and clinicians."

The Face-Off is hosted by the International Society of Computed Tomography (ISCT) and requires radiologists to process and interpret several complex computed tomography (CT) imaging studies. This year each vendor was asked to present oncology follow-up, brain CTA\perfusion, vascular and functional cardiac cases. Four minutes were allowed per case. Again this year Carestream was the only supplier that was able to process all the cases on its fully featured PACS workstation—all the other participants required specialised 3D workstations to handle these cases.

Radiologist Michalle Soudack, M.D., Head of Pediatric Radiology at the Safra Children's Hospital in Israel, presented the cases for Carestream during the event. "MR and CT exams are an integral part of the radiology workflow. Being able to use a PACS workstation with embedded 3D tools to view complex oncology and cardiac cases is another example of the compelling advantages offered by Carestream’s PACS workstation," Michalle Soudack said.

Carestream was one of the first companies to have advanced 3D processing and image analysis tools built into its Vue PACS workstation, with native reporting via digital dictation or voice recognition. Advanced processing capabilities of the CARESTREAM PACS platform include: real-time 3D vessel analysis including automatic abdominal and cardiac vessel segmentation capabilities; automatic registration of volumetric exams including MPR, MIP and MinIP; cardiac exam review; PET-CT reading tools; orthopedic surgical planning; virtual colonoscopy reading and mammography-specific reading tools.

Related news articles:

About Carestream Health
Carestream Health is a worldwide provider of dental and medical imaging systems and healthcare IT solutions; molecular imaging systems for life science research and drug discovery/development; X-ray film and digital X-ray systems for non-destructive testing; and advanced materials for the precision films and electronics markets.

Most Popular Now

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Emotional Cognition Analysis Enables Nea…

A joint research team from the University of Canberra and Kuwait College of Science and Technology has achieved groundbreaking detection of Parkinson's disease with near-perfect accuracy, simply by analyzing brain...

New Recommendations to Increase Transpar…

Patients will be better able to benefit from innovations in medical artificial intelligence (AI) if a new set of internationally-agreed recommendations are followed. A new set of recommendations published in The...

Digital Health Unveils Draft Programme f…

18 - 19 March 2025, Birmingham, UK. Digital Health has unveiled the draft programme for its Rewired 2025 event which will take place at the NEC in Birmingham in March next...

AI System Helps Doctors Identify Patient…

A new study from Vanderbilt University Medical Center shows that clinical alerts driven by artificial intelligence (AI) can help doctors identify patients at risk for suicide, potentially improving prevention efforts...

Smartphone App can Help Reduce Opioid Us…

Patients with opioid use disorder can reduce their days of opioid use and stay in treatment longer when using a smartphone app as supportive therapy in combination with medication, a...

AI's New Move: Transforming Skin Ca…

Pioneering research has unveiled a powerful new tool in the fight against skin cancer, combining cutting-edge artificial intelligence (AI) with deep learning to enhance the precision of skin lesion classification...

Leveraging AI to Assist Clinicians with …

Physical examinations are important diagnostic tools that can reveal critical insights into a patient's health, but complex conditions may be overlooked if a clinician lacks specialized training in that area...

AI can Improve Ovarian Cancer Diagnoses

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images. The study is...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...